259 related articles for article (PubMed ID: 10737679)
1. Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells.
Jacques D; Sader S; El-Bizri N; Chouffani S; Hassan G; Shbaklo H
Can J Physiol Pharmacol; 2000 Feb; 78(2):162-72. PubMed ID: 10737679
[TBL] [Abstract][Full Text] [Related]
2. Bradykinin activates R-, T-, and L-type Ca2+ channels and induces a sustained increase of nuclear Ca2+ in aortic vascular smooth muscle cells.
Bkaily G; Jaalouk D; Jacques D; Economos D; Hassan G; Simaan M; Regoli D; Pothier P
Can J Physiol Pharmacol; 1997 Jun; 75(6):652-60. PubMed ID: 9276144
[TBL] [Abstract][Full Text] [Related]
3. Nonpeptidic antagonists of ETA and ETB receptors reverse the ET-1-induced sustained increase of cytosolic and nuclear calcium in human aortic vascular smooth muscle cells.
Bkaily G; Choufani S; Avedanian L; Ahmarani L; Nader M; Jacques D; D'Orléans-Juste P; Al Khoury J
Can J Physiol Pharmacol; 2008 Aug; 86(8):546-56. PubMed ID: 18758503
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y receptor in cultured vascular smooth muscle cells: ligand binding and increase in cytosolic free Ca2+.
Mihara S; Shigeri Y; Fujimoto M
Biochem Int; 1990 Oct; 22(2):205-12. PubMed ID: 2090091
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation.
Heredia Mdel P; Delgado C; Pereira L; Perrier R; Richard S; Vassort G; Bénitah JP; Gómez AM
J Mol Cell Cardiol; 2005 Jan; 38(1):205-12. PubMed ID: 15623437
[TBL] [Abstract][Full Text] [Related]
6. Presence of neuropeptide Y and the Y1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: modulation of intracellular calcium.
Jacques D; Sader S; Perreault C; Fournier A; Pelletier G; Beck-Sickinger AG; Descorbeth M
Can J Physiol Pharmacol; 2003 Mar; 81(3):288-300. PubMed ID: 12733827
[TBL] [Abstract][Full Text] [Related]
7. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway.
Wang SJ
Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936
[TBL] [Abstract][Full Text] [Related]
8. Activation of sarcolemma and nuclear membranes ET-1 receptors regulates transcellular calcium levels in heart and vascular smooth muscle cells.
Bkaily G; Choufani S; Sader S; Jacques D; d'Orléans-Juste P; Nader M; Kurban G; Kamal M
Can J Physiol Pharmacol; 2003 Jun; 81(6):654-62. PubMed ID: 12839276
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y stimulates DNA synthesis in human vascular smooth muscle cells through neuropeptide Y Y1 receptors.
Nilsson T; Edvinsson L
Can J Physiol Pharmacol; 2000 Mar; 78(3):256-9. PubMed ID: 10721818
[TBL] [Abstract][Full Text] [Related]
10. The role of extracellular calcium in the neuropeptide-Y-induced increase in cytosolic calcium in human erythroleukemic (HEL) cells.
Daniels AJ; Viveros OH; Matthews JE
Mol Cell Neurosci; 1994 Oct; 5(5):466-74. PubMed ID: 7820370
[TBL] [Abstract][Full Text] [Related]
11. Difference between the effects of atrial natriuretic peptide and calcium antagonist on cytosolic free calcium in cultured vascular smooth muscle cells.
Takeuchi K; Abe K; Yasujima M; Sato M; Kasai Y; Tsunoda K; Hagino T; Kanazawa M; Yoshinaga K
J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S13-6. PubMed ID: 2473340
[TBL] [Abstract][Full Text] [Related]
12. Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent.
Nilsson T; Lind H; Brunkvall J; Edvinsson L
Can J Physiol Pharmacol; 2000 Mar; 78(3):251-5. PubMed ID: 10721817
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell-derived vasoconstrictors: mechanisms of action in vascular smooth muscle.
Highsmith RF; Pang DC; Rapoport RM
J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S36-44; discussion S45. PubMed ID: 2473325
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 activates the R-type Ca2+ channel in vascular smooth-muscle cells.
Bkaily G; Naik R; D'Orléans-Juste P; Wang S; Fong CN
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S303-6. PubMed ID: 8587396
[TBL] [Abstract][Full Text] [Related]
15. Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle.
Hoyo Y; McGrath JC; Vila E
J Pharmacol Exp Ther; 2000 Jul; 294(1):38-44. PubMed ID: 10871293
[TBL] [Abstract][Full Text] [Related]
16. Effect of tetrandrine on free intracellular calcium in cultured calf basilar artery smooth muscle cells.
Wang B; Xiao JG
Acta Pharmacol Sin; 2002 Dec; 23(12):1121-6. PubMed ID: 12466050
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide-induced [Ca2+]i transients in cultured bovine trabecular cells.
Ohuchi T; Tanihara H; Yoshimura N; Kuriyama S; Ito S; Honda Y
Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1676-84. PubMed ID: 1559768
[TBL] [Abstract][Full Text] [Related]
18. Blockade of insulin sensitive steady-state R-type Ca2+ channel by PN 200-110 in heart and vascular smooth muscle.
Bkaily G; Economos D; Potvin L; Ardilouze JL; Marriott C; Corcos J; Bonneau D; Fong CN
Mol Cell Biochem; 1992 Nov; 117(1):93-106. PubMed ID: 1336123
[TBL] [Abstract][Full Text] [Related]
19. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
[TBL] [Abstract][Full Text] [Related]
20. PDGF-induced signaling in proliferating and differentiated vascular smooth muscle: effects of altered intracellular Ca2+ regulation.
Egan CG; Wainwright CL; Wadsworth RM; Nixon GF
Cardiovasc Res; 2005 Aug; 67(2):308-16. PubMed ID: 15885673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
